Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Azuma

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Microbial Genomics|November 30, 2021
Genome-wide association study of gastric cancer- and duodenal ulcer-derived <i>Helicobacter pylori</i> strains reveals discriminatory genetic variations and novel oncoprotein candidatesVo Phuoc Tuan, Koji Yahara, Ho Dang Quy Dung, et al.
Microbial Genomics|July 6, 2023
Corrigendum: 'Genome-wide association study of gastric cancer- and duodenal ulcer-derived <i>Helicobacter pylori</i> strains reveals discriminatory genetic variations and novel oncoprotein candidates'Vo Phuoc Tuan, Koji Yahara, Ho Dang Quy Dung, et al.
The Kurume Medical Journal|May 8, 2020
S-1 and CPT-11 Plus Ramucirumab (IRIS+Rmab) as Second-Line Chemotherapy for Patients with Oxaliplatin-Refractory Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study in Japan (N-DOCC-F-C-1701)Kazuma Kobayashi, Michi Morita, Saeko Fukui, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Microbial Genomics|November 30, 2021
Genome-wide association study of gastric cancer- and duodenal ulcer-derived <i>Helicobacter pylori</i> strains reveals discriminatory genetic variations and novel oncoprotein candidatesVo Phuoc Tuan, Koji Yahara, Ho Dang Quy Dung, et al.
Microbial Genomics|July 6, 2023
Corrigendum: 'Genome-wide association study of gastric cancer- and duodenal ulcer-derived <i>Helicobacter pylori</i> strains reveals discriminatory genetic variations and novel oncoprotein candidates'Vo Phuoc Tuan, Koji Yahara, Ho Dang Quy Dung, et al.
The Kurume Medical Journal|May 8, 2020
S-1 and CPT-11 Plus Ramucirumab (IRIS+Rmab) as Second-Line Chemotherapy for Patients with Oxaliplatin-Refractory Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study in Japan (N-DOCC-F-C-1701)Kazuma Kobayashi, Michi Morita, Saeko Fukui, et al.
Pageof 16